Abstract
I read with interest the article by Chung et al. ([1][1]) describing how pretreatment with the serotonin reuptake inhibitor paroxetine (10 mg/d for 6 d) prevented 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine–induced neuroinflammation (increased production of reactive oxygen species and
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
